BioLife Solutions (BLFS) Misses Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $28.49 +0.89%
EPS Growth %: +109.1%
Financial Fact:
Product sales: 2.14M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +109.1%
Financial Fact:
Product sales: 2.14M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $159.5-171 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Constellation Brands (STZ) Tops Q1 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
